Cargando…
BIRB796, an Inhibitor of p38 Mitogen-Activated Protein Kinase, Inhibits Proliferation and Invasion in Glioblastoma Cells
[Image: see text] Glioblastoma (GBM) is the most common malignant tumor, and it is characterized by high cellular proliferation and invasion in the central nervous system of adults. Due to its high degree of heterogeneity and mortality, there is no effective therapy for GBM. In our study, we investi...
Autores principales: | Zhao, Linyao, Wang, Yixuan, Xu, Yang, Sun, Qian, Liu, Hao, Chen, Qianxue, Liu, Baohui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154025/ https://www.ncbi.nlm.nih.gov/pubmed/34056302 http://dx.doi.org/10.1021/acsomega.1c00521 |
Ejemplares similares
-
BIRB796, the Inhibitor of p38 Mitogen-Activated Protein Kinase, Enhances the Efficacy of Chemotherapeutic Agents in ABCB1 Overexpression Cells
por: He, Dan, et al.
Publicado: (2013) -
Of Mice and Monkeys: Neuroprotective Efficacy of the p38 Inhibitor BIRB 796 Depends on Model Duration in Experimental Glaucoma
por: Lambert, Wendi S., et al.
Publicado: (2020) -
BIRB 796 has Distinctive Anti-inflammatory Effects on Different Cell Types
por: Ryoo, Soyoon, et al.
Publicado: (2013) -
The New PI3K/mTOR Inhibitor GNE-477 Inhibits the Malignant Behavior of Human Glioblastoma Cells
por: Wang, Yixuan, et al.
Publicado: (2021) -
TMBIM1 promotes proliferation and attenuates apoptosis in glioblastoma cells by targeting the p38 MAPK signalling pathway
por: Cai, Jiayang, et al.
Publicado: (2022)